North Star Investment Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-5,725
| Closed | -$65K | – | 1035 |
|
2019
Q4 | $65K | Hold |
5,725
| – | – | 0.01% | 509 |
|
2019
Q3 | $62K | Sell |
5,725
-97,550
| -94% | -$1.06M | 0.01% | 511 |
|
2019
Q2 | $968K | Sell |
103,275
-43,900
| -30% | -$411K | 0.11% | 211 |
|
2019
Q1 | $1.81M | Buy |
147,175
+22,300
| +18% | +$274K | 0.21% | 134 |
|
2018
Q4 | $1.48M | Sell |
124,875
-11,000
| -8% | -$130K | 0.19% | 138 |
|
2018
Q3 | $1.96M | Hold |
135,875
| – | – | 0.22% | 128 |
|
2018
Q2 | $2.03M | Sell |
135,875
-40,000
| -23% | -$596K | 0.23% | 120 |
|
2018
Q1 | $2.3M | Sell |
175,875
-22,000
| -11% | -$287K | 0.27% | 101 |
|
2017
Q4 | $2.49M | Sell |
197,875
-300
| -0.2% | -$3.78K | 0.3% | 93 |
|
2017
Q3 | $2.57M | Buy |
198,175
+30,775
| +18% | +$398K | 0.33% | 87 |
|
2017
Q2 | $2.49M | Hold |
167,400
| – | – | 0.33% | 82 |
|
2017
Q1 | $2.01M | Buy |
167,400
+17,000
| +11% | +$204K | 0.28% | 99 |
|
2016
Q4 | $2.08M | Sell |
150,400
-22,125
| -13% | -$305K | 0.31% | 89 |
|
2016
Q3 | $2.31M | Hold |
172,525
| – | – | 0.41% | 73 |
|
2016
Q2 | $1.86M | Hold |
172,525
| – | – | 0.34% | 86 |
|
2016
Q1 | $1.81M | Sell |
172,525
-1,575
| -0.9% | -$16.5K | 0.35% | 81 |
|
2015
Q4 | $2.06M | Sell |
174,100
-3,550
| -2% | -$42K | 0.4% | 71 |
|
2015
Q3 | $2.07M | Hold |
177,650
| – | – | 0.43% | 64 |
|
2015
Q2 | $2.56M | Hold |
177,650
| – | – | 0.47% | 57 |
|
2015
Q1 | $2.48M | Sell |
177,650
-16,624
| -9% | -$232K | 0.46% | 60 |
|
2014
Q4 | $2.68M | Buy |
194,274
+11,524
| +6% | +$159K | 0.51% | 52 |
|
2014
Q3 | $2.24M | Buy |
182,750
+27,125
| +17% | +$332K | 0.45% | 61 |
|
2014
Q2 | $1.94M | Buy |
155,625
+5,000
| +3% | +$62.5K | 0.39% | 69 |
|
2014
Q1 | $1.68M | Buy |
150,625
+100,900
| +203% | +$1.13M | 0.35% | 80 |
|
2013
Q4 | $603K | Buy |
49,725
+250
| +0.5% | +$3.03K | 0.13% | 185 |
|
2013
Q3 | $604K | Buy |
+49,475
| New | +$604K | 0.16% | 159 |
|